Brooks Laboratories Ltd. benchmarking: Performance to industry peers

Financial

	Brooks Laboratories	Coral Laboratories	Ambalal Sarabhai Ent
Operational Metrics
Financials
5 yr Average ROE	0.0	8.16 %	19.11 %
5yr average Equity Multiplier	1.68	1.18	2.07
5yr Average Asset Turnover Ratio	0.62	0.47	0.75
5yr Avg Net Profit Margin	-21.45 %	14.82 %	10.89 %
Price to Book	1.77	1.07	1.52
P/E	8.82	13.65	13.56
5yr Avg Cash Conversion Cycle	23.75 Days	35.5 Days	-37.53 Days
Inventory Days	83.11 Days	69.25 Days	33.51 Days
Days Receivable	80.26 Days	98.13 Days	63.69 Days
Days Payable	163.46 Days	131.4 Days	147.98 Days
5yr Average Interest Coverage Ratio	-11.18	171.88	9.88
5yr Avg ROCE	-11.18 %	10.48 %	24.01 %
5yr Avg Operating Profit Margin	-10.26 %	14.88 %	5.29 %
5 yr average Debt to Equity	0.18	0.02	0.32
5yr CAGR Net Profit	-12.45 %	12.26 %	-30.01 %
5yr Average Return on Assets	-13.31 %	6.95 %	8.69 %
Shareholdings
Promoter Holding	52.62 %	71.51 %	31.36 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-13.79 %	0.0	0.59 %
Change in Mutual Fund Holding (3 Yrs)	9.9 %	0.0	0.0

	Brooks Laboratories	Coral Laboratories	Ambalal Sarabhai Ent
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Formulation of Medicine 0 Electronics 0	Product Wise Break-Up Electronics 0 Formulations 100.0 Pharmaceutical 0	Product Wise Break-Up Electronics 53.67 Formulation of Medicine 0 Pharmaceutical 0 Others 46.33
Segment Break-Up	Segment Break-Up Others 100	-	-
Operating Profit Break-Up	Operating Profit Break-Up Electronics 0 Pharmaceuticals 0 Others 100	-	Operating Profit Break-Up Pharmaceuticals 48.6 Electronics 51.4
Asset Break-Up	Asset Break-Up Electronics 0 Pharmaceuticals 0 Others 100	-	Asset Break-Up Pharmaceuticals 73.71 Electronics 26.29